Neuralink approved for second brain implant patient by FDA

Neuralink, Elon Musk's brain implant company, receives FDA approval for a second human trial patient. The chip, part of the PRIME Study, aims to help quadriplegic individuals control devices with their thoughts. Over 100 quadriplegic people have signed up for the trial. The first patient, Noland Arbaugh, shared positive experiences with the implant. Neuralink plans to implant up to 10 people by year-end.